These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 4144467

  • 1. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER, Gallagher MT, Trentin JJ.
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of the graft-versus-host reaction. III. Altered in vivo distribution of spleen cells pretreated with Fab fragments of antithymocyte globulin.
    Richie ER, Monié HJ, Trentin JJ, Taub RN.
    Transplantation; 1975 Feb; 19(2):115-20. PubMed ID: 235162
    [Abstract] [Full Text] [Related]

  • 3. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H, Therfelder S, Eulitz M.
    Exp Hematol; 1974 Feb; 2(4):195-203. PubMed ID: 4156327
    [No Abstract] [Full Text] [Related]

  • 4. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
    Trentin JJ, Judd KP.
    Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT, Richie ER, Heim LR, Judd KP, Trentin JJ.
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of allograft reactivity in vitro and in vivo, by Fab fragments obtained from ALG.
    Gallagher MT, Richie ER, Trentin JJ.
    Transplant Proc; 1973 Mar; 5(1):869-72. PubMed ID: 4144466
    [No Abstract] [Full Text] [Related]

  • 7. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G, Kiger N, Florentin I, Garcia-Giralt E, Martyre MC, Halle-Pannenko O, Schwartzenberg L.
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract] [Full Text] [Related]

  • 8. The double barrier in bone marrow transplantation.
    van Bekkum DW.
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract] [Full Text] [Related]

  • 9. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C, Ilbery PL.
    Exp Hematol; 1973 Jul; 1(1):3-10. PubMed ID: 4154047
    [No Abstract] [Full Text] [Related]

  • 10. Modification of graft-vs-host disease following bone marrow transplantation in germfree mice.
    Bealmear PM, Mirand EA, Holtermann OA.
    Prog Clin Biol Res; 1983 Jul; 132C():409-21. PubMed ID: 6227014
    [No Abstract] [Full Text] [Related]

  • 11. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM, Rimm AA, Saltzstein EC, Rodey GE.
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract] [Full Text] [Related]

  • 12. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
    Rodt H, Thierfelder S, Eulitz M.
    Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
    Müller-Ruchholtz W, Wottge HU, Müller-Hermelink HK.
    Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
    [No Abstract] [Full Text] [Related]

  • 14. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA.
    J Immunol; 1993 Jan 01; 150(1):265-77. PubMed ID: 8417127
    [Abstract] [Full Text] [Related]

  • 15. Thymus dependence of lymphocyte trapping.
    Zatz MM, Gershon RK.
    J Immunol; 1974 Jan 01; 112(1):101-6. PubMed ID: 4149589
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of antilymphocyte serum on the redifferentiation of hematopoietic stem cells by syngeneic lymphocytes].
    Golovistikov IN, Bliakher MS, Zykov IuV.
    Dokl Akad Nauk SSSR; 1972 Jun 01; 204(4):980-2. PubMed ID: 4557586
    [No Abstract] [Full Text] [Related]

  • 17. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
    Johnson BD, McCabe C, Hanke CA, Truitt RL.
    J Immunol; 1995 May 15; 154(10):5542-54. PubMed ID: 7730653
    [Abstract] [Full Text] [Related]

  • 18. Beneficial influence of limited histocompatibility of bone marrow grafted to unrelated rhesus monkeys preconditioned with x-ray and ALS.
    Neffe JR, Merritt CB, Darrow CC, Rogentine GN.
    Transplant Proc; 1974 Jun 15; 6(2):125-8. PubMed ID: 4208750
    [No Abstract] [Full Text] [Related]

  • 19. Functional properties of segregated lymphocytes.
    Lance E, Cooper S.
    Transplant Proc; 1973 Mar 15; 5(1):119-24. PubMed ID: 4144456
    [No Abstract] [Full Text] [Related]

  • 20. [An attempt to prevent lymphoid atrophy in secondary disease of radiation chimeras by means of transplanting the lymphocytes of a recipient].
    Koval'chuk LV, Zaretskaia IuM.
    Biull Eksp Biol Med; 1967 Oct 15; 63(10):82. PubMed ID: 4914553
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.